Skip to main navigation
Skip to search
Skip to main content
Luxembourg Institute of Health Home
Home
Profiles
Research units
Research output
Projects
Equipment
Datasets
Search by expertise, name or affiliation
A multi-omics based single-cell strategy to overcome therapy-driven resistance in Glioblastoma: An entry-point for personalized treatment
Niclou, Simone
(PI)
Hau, Ann-Christin
(PI)
Kumar, Suresh
(PI)
Department of Cancer Research
NORLUX Neuro-Oncology Laboratory
Luxembourg Center of Neuropathology
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Tamsulosin
100%
Glioblastoma
100%
Neoplasm
40%
Brain Cancer
40%
Disease Exacerbation
40%
Chemotherapy
20%
Tumor Recurrence
20%
Life Expectancy
20%
Glioma
20%
Combination Therapy
20%
Disease
20%
Malignant Neoplasm
20%
Intracranial Tumor
20%
Immunology and Microbiology
Multi-Omics
100%
Xenograft
100%
Clonal Evolution
50%
Genetic Heterogeneity
50%
Transcriptomics
50%
Cell Level
50%
Life Expectancy
50%
Biochemistry, Genetics and Molecular Biology
Tamsulosin
100%
Genetics
50%
Genetic Heterogeneity
50%
Clonal Evolution
50%
Cell Level
50%
Life Expectancy
50%
Transcriptomics
50%